Literature DB >> 18383834

EpCAM overexpression is associated with high-grade urothelial carcinoma in the renal pelvis.

Andrea Brunner1, Georg Schaefer, Lothar Veits, Barbara Brunner, Martina Prelog, Christian Ensinger.   

Abstract

BACKGROUND: EpCAM serves as an attractive target for immunotherapy due to its expression on the surface of most epithelial cancer cells. Urothelial carcinoma of the renal pelvis (RP-UC) comprises 2.4-4.6% of tumors of the lower urinary tract. To assess the expression of EpCAM in RP-UC a retrospective study was performed. PATIENTS AND METHODS: Tumor tissue from 42 patients with RP-UC was selected from the archives of the Institute of Pathology, Medical University of Innsbruck, Austria. EpCAM expression was demonstrated by immunohistochemistry using the mouse monoclonal antibody ESA.
RESULTS: EpCAM overexpression was significantly associated with high grade and invasive behaviour (p = 0.014 and p = 0.029) and the presence of lymph node metastases (p = 0.031), but not with the extent of nodal involvement (p = 0.12).
CONCLUSION: In RP-UC, EpCAM overexpression is associated with an aggressive tumor phenotype. The association of EpCAM overexpression with the presence of lymph node metastasis may be of prognostic and therapeutic relevance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18383834

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Destabilization of EpCAM dimer is associated with increased susceptibility towards cleavage by TACE.

Authors:  Tomaž Žagar; Miha Pavšič; Aljaž Gaber
Journal:  PeerJ       Date:  2021-05-21       Impact factor: 2.984

2.  EpCAM knockdown alters microRNA expression in retinoblastoma--functional implication of EpCAM regulated miRNA in tumor progression.

Authors:  Madhu Beta; Vikas Khetan; Nivedita Chatterjee; Ganesan Suganeswari; Pukhraj Rishi; Jyotirmay Biswas; Subramanian Krishnakumar
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

3.  EpCAM Expression in Lymph Node Metastases of Urothelial Cell Carcinoma of the Bladder: A Pilot Study.

Authors:  Christa A M van der Fels; Stefano Rosati; Igle J de Jong
Journal:  Int J Mol Sci       Date:  2017-08-18       Impact factor: 5.923

4.  Potential Receptors for Targeted Imaging of Lymph Node Metastases in Penile Cancer.

Authors:  Christa A M van der Fels; Selma Palthe; Henk Buikema; Marius C van den Heuvel; Annemarie Leliveld; Igle Jan de Jong
Journal:  Diagnostics (Basel)       Date:  2020-09-15

Review 5.  Current View on EpCAM Structural Biology.

Authors:  Aljaž Gaber; Brigita Lenarčič; Miha Pavšič
Journal:  Cells       Date:  2020-05-31       Impact factor: 6.600

6.  EpCAM homo-oligomerization is not the basis for its role in cell-cell adhesion.

Authors:  Aljaž Gaber; Seung Joong Kim; Robyn M Kaake; Mojca Benčina; Nevan Krogan; Andrej Šali; Miha Pavšič; Brigita Lenarčič
Journal:  Sci Rep       Date:  2018-09-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.